Indian fertilizer, specialty chemical industries hit by US-Iran war
India, one of the world’s largest importers of oil and natural gas, is among the countries hardest hit…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
India’s coming Ozempic moment could reshape both waistlines and perceptions
On a recent episode of CBS Sports Golazo, Clint Dempsey couldn’t resist a dig. Sitting alongside Thierry Henry,…
Don't advertise weight-loss drugs: Govt to pharma firms | 'Obesity 'awareness campaigns' also misleading' | Inshorts – Inshorts
Don’t advertise weight-loss drugs: Govt to pharma firms | ‘Obesity ‘awareness campaigns’ also misleading’ | Inshorts InshortsDrug regulator bars…
What Big Pharma Won’t Tell You: The Ancient Natural Remedy People Swear By — and It Costs Almost Nothing
Claims that “Big Pharma doesn’t want you to know” about a powerful, nearly free natural remedy circulate widely…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 2028
Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks – and life…
All the economic wins Keir Starmer wants to bag in China – POLITICO
For now, then, the aim is to secure progress in areas that are seen as less sensitive. Starmer’s…
Eli Lilly-backed Insilico eyes beyond pharma with new AI models
Interview Biotech company shares jumped 46% in $300m Hong Kong debut Biotech firm Insilico Medicine leverages artificial intelligence…
China’s new commercial insurance model could broaden access to Alzheimer’s drugs
China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…
10 Healthcare Industry Predictions For 2026
The year 2026 will be a year of tumult in American healthcare. Getty Images As December kicks off,…